OncoSec Medical Inc (ONCSQ)

[hschlauch]

These TNBC patients received a single cycle of EP encoded IL-12. The trial was not designed to test overall responses. It was intended to investigate immune responses, safety and bio distribution of IL-12. If a patient goes off protocol and immediately on to an anti-PD-1, then there might be interesting tidbits. But, my point is that this small trial was in no way intended to report response rates. In my opinion, the TIL data are far more important anyhow.